Update TOP 100 Public Voting 2024: Recolony, Haya Therapeutics, and Navignostics lead the Biotech field

The voting process has begun, marking the first update of the TOP 100 Public Voting 2024. Our focus this week is on Biotech, where Recolony, Haya Therapeutics, and Navignostics are currently in the lead. However, it's important to remember that the TOP 100 Public Voting 2024 is a marathon, not a sprint. We encourage everyone with a LinkedIn account to continue casting their votes as the competition progresses. You can select the 10 most innovative Swiss startups until July 21, 2024.

Every year, the TOP 100 Swiss Startup Award showcases the 100 most innovative and promising Swiss startups chosen by a 100-strong jury of leading investors and experts. The TOP 100 Public Vote runs parallel to the expert jury ranking and highlights outstanding Swiss startups that will be celebrated on stage at the award night on September 4, 2024.

This year, we will honor one Public Voting winner for each of the 10 verticals (Biotech, Cleantech, Engineering, Fintech, Foodtech, ICT, Medtech, Proptech, Robotics, and Security). We will provide updates for each vertical separately to keep up the suspense. This year we begin with the Biotech vertical, where a tight race is underway between Recolony, Haya Therapeutics, and Navignostics. Innovators in the Biotech sector are creating products that harness cellular and biomolecular processes to help improve our lives and the health of our planet. Discover the three Swiss Biotech solutions that have received the most TOP 100 votes so far:


1. Recolony: The startup focus is fighting cancer with a two-pronged approach. The first product is a unique, orally-delivered LBP targeting various solid tumors. This bacterial therapy works by stimulating specific immune cells through a well-defined mechanism, which Recolony has identified.
2. Haya Therapeutics: HAYA is dedicated to treating heart failure through the discovery and development of innovative first-in-class RNA-based therapeutics, with a specific focus on long noncoding RNAs.
3. Navignostics: The startup characterizes tumors using spatial single-cell proteomics. It identifies a cancer treatment that will optimally fight each patient's tumor.

The race is still wide open, so keep spreading the word! Startups can share the link to the startup.ch voting page with friends, family, and followers and encourage everyone in the network to vote for them. Remember, every vote counts! 

Even though there is no award for the most creative TOP 100 Public Voting tweet, we are impressed by your ideas! Follow the hashtag #TOP100SSU on Twitter and LinkedIn to stay up to date on the results and see the creativity of Swiss startups! 

How you can vote for your favorite TOP 100 Swiss startup
All Swiss startups listed on startup.ch and incorporated on or after January 1st, 2019, are eligible for your vote.
Voting is as easy as 1-2-3:

1. Visit https://www.startup.ch/publicvoting2024 for a list of all eligible startups.
2. Choose your winning startup and click the golden “Vote now” button on the startup’s profile.
3. Login with your LinkedIn profile. Each user has one vote. Happy voting!

All votes have to be in by midnight on July 21, 2024.